Here the vitamin D receptor serves as a regulator of PSC activation, and vitamin D receptor agonists revert PSCs to a quiescent state, reducing tumor fibrosis and enhancing delivery of chemotherapeutics [16]. The gene discussed is VDR; the disease is neoplasm.